Motoric cognitive risk syndrome: prevalence and associated sociodemographic and clinical factors in primary care settings in Brazil
Alzheimer's & Dementia · 2025
DOI: 10.1002/alz.70903 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Lílian Viana Dos Santos Azevedo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Behavioral and Cognitive Neurology Unit, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil. Hauptthemen laut MEDLINE: Primary Health Care, Cognitive Dysfunction. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
INTRODUCTION Motoric cognitive risk syndrome (MCR) is a pre‐dementia condition characterized by subjective memory complaints and slow gait, and it is associated with increased risk of dementia and mortality. This study investigated MCR prevalence in a Brazilian community sample and its associations with sociodemographic and clinical factors. METHODS Cross‐sectional study conducted in four public primary care settings. Sociodemographic, clinical, motor, and cognitive aspects were assessed. RESULTS The sample included 355 individuals (mean age = 71.4 years, 69.6% women). The prevalence of MCR was 11.3%. Univariate analysis showed associations with older age, lower education, inactivity, falls, polypharmacy, depression, stroke, poor Addenbrooke's Cognitive Examination‐Revised (ACE‐R) performance, and higher Unified Parkinson's Disease Rating Scale, subsection III (UPDRS‐III) scores. Multivariate analysis confirmed significant associations with falls (odds ratio [OR] = 14.4, 95% CI: 5.5 to 37.4), polypharmacy (OR = 4.3, 95% CI: 1.8 to 10.3), and UPDRS‐III scores (OR = 1.1, 95% CI: 1.03 to 1.17). DISCUSSION The prevalence of MCR was 11.3% in Brazilian older adults and was linked to polypharmacy, falls, and parkinsonian signs, highlighting its value for early and low‐cost identification in primary care. Highlights Prevalence of MCR was 11.3% in Brazilian older adults. MCR was independently associated with falls, polypharmacy, and parkinsonian signs. Findings highlight low‐cost clinical markers for early dementia risk identification. Results support integration of MCR screening into primary care in low‐ and middle‐income countries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Behavioral and Cognitive Neurology Unit, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
- Programa de Pós-Graduação em Neurociência Translacional, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Rajasthan, Brazil.
- Faculdade Ciências Médicas de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
- Programa de Pós-Graduação em Neurociências, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
ORCID-Profile: Lílian Viana Dos Santos Azevedo, Paulo Caramelli
Zitieren
APA
Azevedo, L. V. D. S., Marques, A. M. D. S., Silva-Júnior, G. A., de Santos, G. S. S., Faria, L. P., Taveira, M. L., Nascimento, M., Barbosa, M. T., & Caramelli, P. (2025). Motoric cognitive risk syndrome: prevalence and associated sociodemographic and clinical factors in primary care settings in Brazil. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70903
Vancouver
Azevedo LVDS, Marques AMDS, Silva-Júnior GA, de Santos GSS, Faria LP, Taveira ML, et al. Motoric cognitive risk syndrome: prevalence and associated sociodemographic and clinical factors in primary care settings in Brazil. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70903
BibTeX
@article{Azevedo2025,
author = {Azevedo, Lílian Viana Dos Santos and Marques, Alice Moreira Dos Santos and Silva-Júnior, Geraldo Alves and de Santos, Giselle Stephanie Sousa and Faria, Laura Pereira and Taveira, Maria Luíza and Nascimento, Marina and Barbosa, Maira Tonidandel and Caramelli, Paulo},
title = {Motoric cognitive risk syndrome: prevalence and associated sociodemographic and clinical factors in primary care settings in Brazil},
journal = {Alzheimer's & Dementia},
year = {2025},
doi = {10.1002/alz.70903}
}
EUVIMED